Department of Pharmacology

April 23, 2015

Lecture explores efforts to move pharmacogenetics into the clinic

Preemptive genotyping: It sounds like a surprise attack, and it is.

By Bill Snyder
April 3, 2015

Cancer signaling pathway blocker

Researchers at Vanderbilt University have discovered a new way to inhibit Hedgehog (Hh) signaling, an important regulatory pathway for vertebrate development – and cancer.

By VUMC News and Communications
April 2, 2015

Pharmacogenomics expert set for Wilkinson Lecture

Mary Relling, Pharm.D., chair of the Department of Pharmaceutical Sciences at St. Jude Children’s Research Hospital in Memphis, will deliver this year’s Grant R. Wilkinson Distinguished Lecture in Clinical Pharmacology on Thursday, April 9.

By Bill Snyder
January 23, 2015

New view of dopamine heteromers

Although heteromeric dopamine receptors composed of both D1 and D2 subunits have been proposed to play a role in depression and schizophrenia, recent studies suggest these heteromers do not exist.

By VUMC News and Communications
January 9, 2015

Does fish oil help prevent A-fib?

Growing evidence suggests that fish oil, thought to directly prevent inflammation, oxidative stress and heart disease, may have limited clinical utility.

By VUMC News and Communications
Heart illustration thumbnail
December 18, 2014

Atrial disease and hypertension links

New findings suggest that misfolded proteins accumulate in the heart atria, particularly in patients with hypertension, and may contribute to atrial heart disease.

By Leigh MacMillan
December 11, 2014

Bacterial secretion machinery: 3-D view

New structural findings reveal how "gatekeeper" proteins participate in the secretion systems bacteria use to infect host cells.
By Leigh MacMillan
November 25, 2014

Protein implicated in atherosclerosis

Vanderbilt researchers have discovered a new target for the prevention of atherosclerotic plaque development and cardiovascular disease.
By VUMC News and Communications
October 9, 2014

Nobel laureate sheds light on immune response system

Peter Doherty, Ph.D., had some advice for young scientists at last week’s Flexner Discovery Lecture. The way to win a Nobel Prize, he said, “is to make a very big discovery first.”
By Leigh MacMillan
September 30, 2014

Seizure mutation impairs receptor

Defects in the production of certain receptors are linked to the pathogenesis of genetic epilepsies and fever-induced seizures.
By Yan Su
September 25, 2014

Doherty set for next Discovery Lecture

Nobel laureate Peter Doherty, Ph.D., who discovered how the immune system recognizes virus-infected cells, will deliver the next Flexner Discovery Lecture on Thursday, Oct. 2.
By Leigh MacMillan
September 12, 2014

Schizophrenia ‘switches’ discovered

Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way.
By Bill Snyder
September 11, 2014

Bone healing therapy for NF1 fractures

A combination treatment delivered to the site of fractures may improve bone healing in patients with the genetic disease neurofibromatosis type-1.
By VUMC News and Communications
1 … 9 10 11 12 13 14